Literature DB >> 22983769

Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China.

Hui Lin1, James Cheng-chung Wei, Chun-yu Tan, Yuan-yuan Liu, Yan-hong Li, Feng-xia Li, Dai-hua Deng, Bing Yan, Yi Liu, Yi Zhao.   

Abstract

The aim of this study is to explore the survival rate and risk factors of mortality in patients with late-onset systemic lupus erythematosus (SLE) in a large cohort. Clinical presentations, disease activity, organ damage scores, autoantibody profile, and mortality data were obtained retrospectively from late-onset SLE patients (onset age ≥50 years) diagnosed between 1995 and 2009. The risk factors of organ damage were evaluated by the chi-square test and logistic regression. The cumulative rate of survival was calculated by Kaplan-Meier method, and factors predictive of mortality were studied by Cox proportion hazard regression model. A total of 158 patients (132 female and 26 male) were studied. The average onset age was 58.66 ± 6.38 years and mean disease duration was 63.85 ± 48.17 months. One hundred and four patients had organ damage at the time of data analysis. Hematological system and kidney involvement were most common. Central nervous system involvement was relatively rare. In univariate logistic analysis, associations were found between SLE disease activity index (SLEDAI) at diagnosis (OR = 1.133, P = 0.001); renal involvement (OR = 2.441, P = 0.009) and edema (OR = 2.812, P = 0.003) were associated with organ damage. And SLEDAI at diagnosis (OR = 1.103, P = 0.034) was independent factor for organ damage in multivariate logistic regression. During the follow-up, 64 patients (51 female and 13 male) died. Five-, 10-, and 15-year survival rates were 80.4, 56.5, and 31.7 %, respectively. Median survival time was 123 months. The analysis of Cox proportion hazard regression model showed that age at disease onset (OR = 1.069, P = 0.002), compliance of medical care (OR = 3.282, P = 0.001), and SLEDAI at diagnosis (OR = 1.091, P = 0.003) were independent risk factors of mortality. Late-onset SLE has a poor long-term prognosis. Infection is the major cause of death in patients with late-onset lupus. Disease activity, medical care, and onset age are strongly related to death of late-onset SLE.

Entities:  

Mesh:

Year:  2012        PMID: 22983769     DOI: 10.1007/s10067-012-2073-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.

Authors:  Hermine I Brunner; Earl D Silverman; Theresa To; Claire Bombardier; Brian M Feldman
Journal:  Arthritis Rheum       Date:  2002-02

2.  A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus.

Authors:  M M Ward; R P Polisson
Journal:  Arthritis Rheum       Date:  1989-10

Review 3.  Prognosis and treatment of systemic lupus erythematosus.

Authors:  D D Gladman
Journal:  Curr Opin Rheumatol       Date:  1996-09       Impact factor: 5.006

4.  Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset.

Authors:  L T Costallat; A M Coimbra
Journal:  Clin Exp Rheumatol       Date:  1994 Nov-Dec       Impact factor: 4.473

5.  Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.

Authors:  Malik Anas Rabbani; H B Habib; M Islam; B Ahmad; S Majid; W Saeed; S M A Shah; A Ahmad
Journal:  Lupus       Date:  2009-08       Impact factor: 2.911

6.  Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes.

Authors:  M M Ward; E Pyun; S Studenski
Journal:  Arthritis Rheum       Date:  1995-02

Review 7.  Systemic lupus erythematosus in the elderly.

Authors:  J Rovenský; A Tuchynová
Journal:  Autoimmun Rev       Date:  2007-12-03       Impact factor: 9.754

8.  Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.

Authors:  D D Gladman; C H Goldsmith; M B Urowitz; P Bacon; C Bombardier; D Isenberg; K Kalunian; M H Liang; P Maddison; O Nived
Journal:  J Rheumatol       Date:  1994-08       Impact factor: 4.666

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

View more
  11 in total

1.  Clinical manifestations and survival among adults with (SLE) according to age at diagnosis.

Authors:  J F Merola; B Bermas; B Lu; E W Karlson; E Massarotti; P H Schur; K H Costenbader
Journal:  Lupus       Date:  2014-03-07       Impact factor: 2.911

2.  Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus.

Authors:  Chengcheng Hou; Ou Jin; Xi Zhang
Journal:  Clin Rheumatol       Date:  2018-07-09       Impact factor: 2.980

3.  Obesity and the risk of systemic lupus erythematosus among women in the Nurses' Health Studies.

Authors:  Sara K Tedeschi; Medha Barbhaiya; Susan Malspeis; Bing Lu; Jeffrey A Sparks; Elizabeth W Karlson; Walter Willett; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2017-05-25       Impact factor: 5.532

4.  Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study.

Authors:  Lihui Wen; Ziyan Chen; Ziyi Jin; Wenyou Pan; Lin Liu; Min Wu; Fuwan Ding; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Xuebing Feng; Jun Liang; Huayong Zhang; Lingyun Sun
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

5.  Discriminating infectious meningitis versus neuropsychiatric involvement in patients with systemic lupus erythematosus: a single-center experience.

Authors:  Jinyun Chen; Xuebing Feng; Hong Wang; Bingzhu Hua; Congzhu Ding; Bujun Liu; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2014-06-20       Impact factor: 2.980

6.  Complement levels and risk of organ involvement in patients with systemic lupus erythematosus.

Authors:  Ignacio Javier Gandino; Marina Scolnik; Emmanuel Bertiller; Valeria Scaglioni; Luis Jose Catoggio; Enrique Roberto Soriano
Journal:  Lupus Sci Med       Date:  2017-06-25

7.  T cell subsets and immunoglobulin G levels are associated with the infection status of systemic lupus erythematosus patients.

Authors:  Lifen Wu; Xinru Wang; Fenghua Chen; Xing Lv; Wenwen Sun; Ying Guo; Hou Hou; Haiyan Ji; Wei Wei; Lu Gong
Journal:  Braz J Med Biol Res       Date:  2017-12-11       Impact factor: 2.590

8.  Methodological quality of cohort study on rheumatic diseases in China: A systematic review.

Authors:  Huan Zhang; Guoxiang Yi; Mingzhu Dai; Yanping Li; Bin Wu
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

9.  Lysogenic Streptococcus suis isolate SS2-4 containing prophage SMP showed increased mortality in zebra fish compared to the wild-type isolate.

Authors:  Fang Tang; Wei Zhang; Chengping Lu
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

Review 10.  Global epidemiology of systemic lupus erythematosus.

Authors:  Megan R W Barber; Cristina Drenkard; Titilola Falasinnu; Alberta Hoi; Anselm Mak; Nien Yee Kow; Elisabet Svenungsson; Jonna Peterson; Ann E Clarke; Rosalind Ramsey-Goldman
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 32.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.